Amoéba
Tracked across 1 events · 7 articles · First seen Jun 30, 2026 · Last active Jul 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Amoéba obtained marketing authorization for its biofungicide AXPERA in France, which is crucial for the launch of its commercialization phase and future expansion in Europe. This significantly boosts the company's market position and revenue potential.
Jun 30, 2026 · 7 articles
90
Argentina — National Social Security Administration (Argentina) granted authorization AmoébaAmoéba AXPERA Biofungicide...
85
Amoéba obtained authorizationAmoéba AXPERA Biofungicide...
70
Amoéba submitted applicationsAmoéba AXPERA Biofungicide...
ERGEN INTELLIGENCE
Track Amoéba live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard